DDNews published an article on the i2b2 tranSMART Foundation's announcement on our collaboration with IBM. The article also discussed the merger between the i2b2 and tranSMART Foundations.
Read the entire article.
The i2b2 tranSMART Foundation has launched its new Partnership Program. Partners are the cornerstone of the Foundation and frequent contributors to the community. The new program offers organizations the opportunity to interact and advise the Board, management team and Project Management Committees as well as provide financial support to the Foundation and its activities.
In offering multiple levels of engagement, each with organization size sub-levels, corporate, non-profit and academic institutions can more fully participate in the development and evolution of the Foundation.
More details and the Partnership application can be found here.
The 5th i2b2 European Academic Users Group (Eu-AUG) Scientific is pleased to invite submissions of scientific presentations and posters.
Please submit your proposal via the web site (http://blogs.aphp.fr/i2b2/submit/).
Extended Submission Deadline: July 31st, 2017, 11:59 p.m. CET (Central European Time)
The 5th European AUG meeting
Assistance Publique-Hôpitaux de Paris (AP-HP) and affiliated universities are organizing the 5th edition of the i2b2 EU-AUG meeting in October 2017. The conference with prestigious speakers will spotlight – in the context of i2b2 implementation – hot topics such as big data challenges for healthcare, networking data for better care, extending data repositories beyond clinical data and the view of patients on the benefits of reusing their data for research. Participation is upon registration only, but free, although participants will need to cover their own travel costs.
RegistrationMay we kindly invite you to register your interest via the (http://blogs.aphp.fr/i2b2/register/)
The i2b2 Foundation and the tranSMART Foundation announced that they have completed their merger. The new foundation is called the i2b2 tranSMART Foundation. Their new website can be found at http://www.i2b2transmart.org. Details of the merger were described in a press release earlier today. See their website for more details and learn about their new governance structure, the Board of Directors and management team. There are also details on their new Membership and Sponsorship programs as well as how to access their popular open-source software platforms for translational and clinical research.
In an article by Alex Keown, BioSpace.com Breaking News Staff, in their May 24th issue, he reported " Biotech researchers looking to harness the power of big data could have an easier time with the new partnership between IBM (IBM) and the tranSMART Foundation, a Massachusetts-based nonprofit organization founded in 2012 with a goal of providing a platform to share pre-competitive data for use in designing transformational medicines." The article goes on to describe the merger with the i2b2 Foundation as well as some of the history, while focusing on the new version of the tranSMART Platform on the IBM Power8 server. READ THE FULL ARTICLE HERE
Neil Versel (GenomeWeb) wrote "As genomic tools continue to make their way from the research lab into clinical practice, the recently announced merger between the TranSmart Foundation and the Informatics for Integrating Biology and the Bedside (i2b2) aims to provide researchers and clinicians with an open-source resource that could benefit precision medicine efforts." Earlier this month, the two organizations announced their plans to combine into a single foundation focused on providing open-source biomedical software and databases for precision medicine. "We're creating an entire open-source home for people who want to bring precision medicine into clinical practice," said tranSMART Foundation CEO Keith Elliston. Read More HERE.
Andy Oram writes in EMR & HIPPA (HealthcaseScene.com) about the potential merger of the i2b2 Foundation with the tranSMART Foundation. Andy reflects "as a harbinger of progress in medicine, the announcement is very significant". Andy continues "Their timely merger shows that open source overcomes cultural and institutional barriers... Ultimately, they’ll contribute to the movement to target cures to patients, proceeding now under the name Precision Medicine." Read the full article. Andy Oram is an editor at O'Reilly Media, a highly respected book publisher and technology information provider. An employee of the company since 1992, Andy currently specializes in open source, software engineering, and health IT,
In a Press Release released today, the i2b2 Foundation and the tranSMART Foundation announced that they have signed a Letter of Intent to merge the two foundations. While no further details were announced, both management teams are working to complete the merger in the next few months. Together, the combined tranSMART and i2b2 foundations will enhance the synergies between their two distinct data science platforms and will further develop an integrated, open-source platform that spans the clinical and translational research domains. See the full Press Release HERE.
In citing a recent report from KPMG and another by PwC , Taren Grom talks about the need for collaboration in today's research and development activities for health care researchers. In PwC's report on Pharma in 2020, they talk about collaboration as a "do or die" situation. Grom goes on to discuss how the tranSMART platform is being used for these efforts. Further, the technology is now in place to facilitate these sorts of interactions between research groups from all sectors. The transMART Foundation is cited as one of those technologies, fosters by its industry/academia Members and a broad spectrum research community of users. See the PharmaVOICE Posted Story
The tranSMART Foundation announced the newest release of its tranSMART platform, version 16.2. This version includes significant contributions from numerous members of the tranSMART community and provides users with more advanced functionality to enhance their translational research studies. The newly developed features in version 16.2 include the SmartR plugin (ITTM/University of Luxembourg/eTRIKS), genomics-based cohort selection (Janssen), GWAS enhancements (Pfizer), GWAS PLINK integration (Clarivate Analytics), XNAT image database integration (Imperial College London and Erasmus Medical Center), and ETL enhancements (Imperial College London/eTRIKS). “As an open-source platform, tranSMART wouldn’t be possible without the contributions of our community,” said Keith Elliston, Ph.D., CEO of the Foundation. “We are delighted that so many organizations have stepped up to the plate to support further development of the platform. It is a true testament to what open-source communities can offer and the value of collaboration among individuals and organizations in the scientific and technical communities.” The expanding capabilities of the tranSMART platform provide the translational research community with an improved set of tools. For example, SmartR plugin offers the ability to tap into the richness of R to provide workflows for Boxplot, correlation, heat map line graph, and volcano plots. Others will be added in upcoming releases. In addition, there is a workflow that provides a link to the Qiagen Ingenuity Pathway Analysis. Another example is the Janssen contributed genomics cohort selection, HiDome, which supports the use of gene expression and other high dimensional data in the Comparison and Summary Statistics tabs to build cohorts. Each of these contributions has followed tranSMART’s contributor process and guidelines, producing a product that has been subjected to automated testing all along the process. The 16.2 release exemplifies the Foundation’s ability to bring new innovations to the platform from a variety of community contributors, while maintaining the quality and reliability of the platform through its release process.